These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 1394027

  • 21. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan 20; 32(1):6-8. PubMed ID: 7635005
    [Abstract] [Full Text] [Related]

  • 22. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
    Priest RG, Gimbrett R, Roberts M, Steinert J.
    Acta Psychiatr Scand Suppl; 1995 Jan 20; 386():40-3. PubMed ID: 7717094
    [Abstract] [Full Text] [Related]

  • 23. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M, Moll E.
    Acta Psychiatr Scand Suppl; 1990 Jan 20; 360():43. PubMed ID: 2248067
    [Abstract] [Full Text] [Related]

  • 24. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J, Kneer J, Fotteler B, Groen H, Peeters PA, Jonkman JH.
    J Clin Psychopharmacol; 1995 Feb 20; 15(1):41-8. PubMed ID: 7714227
    [Abstract] [Full Text] [Related]

  • 25. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
    Larsen JK, Holm P, Mikkelsen PL.
    Acta Psychiatr Scand; 1984 Sep 20; 70(3):254-60. PubMed ID: 6388247
    [Abstract] [Full Text] [Related]

  • 26. The role of moclobemide in endogenous depression: a survey of recent data.
    Woggon B.
    Int Clin Psychopharmacol; 1993 Jan 20; 7(3-4):137-9. PubMed ID: 8468434
    [Abstract] [Full Text] [Related]

  • 27. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ, Aarons SF, Frances AJ, Brown RD.
    J Clin Psychiatry; 1984 Jul 20; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [Abstract] [Full Text] [Related]

  • 28. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun 20; 28(2):105-16. PubMed ID: 8354766
    [Abstract] [Full Text] [Related]

  • 29. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W.
    Acta Psychiatr Scand Suppl; 1990 Jun 20; 360():57-8. PubMed ID: 2248073
    [Abstract] [Full Text] [Related]

  • 30. The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
    Bech P, Stage KB, Larsen JK, Vestergaard P, Gram LF, DUAG.
    J Affect Disord; 2012 Nov 20; 140(3):253-9. PubMed ID: 22381949
    [Abstract] [Full Text] [Related]

  • 31. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M, Amrein R, Stabl M.
    Int Clin Psychopharmacol; 1997 Jul 20; 12(4):183-93. PubMed ID: 9347378
    [Abstract] [Full Text] [Related]

  • 32. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.
    Fitton A, Faulds D, Goa KL.
    Drugs; 1992 Apr 20; 43(4):561-96. PubMed ID: 1377119
    [Abstract] [Full Text] [Related]

  • 33. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression.
    Paykel ES.
    Acta Psychiatr Scand Suppl; 1995 Apr 20; 386():22-7. PubMed ID: 7717091
    [Abstract] [Full Text] [Related]

  • 34. [Moclobemide in the treatment of depression--an overview].
    Laux G.
    Psychiatr Prax; 1989 Aug 20; 16 Suppl 1():37-40. PubMed ID: 2685855
    [Abstract] [Full Text] [Related]

  • 35. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R, Berchou R, Rainey JM.
    J Clin Psychopharmacol; 1982 Dec 20; 2(6):399-407. PubMed ID: 7174863
    [Abstract] [Full Text] [Related]

  • 36. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul 20; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 37. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
    Guelfi JD, Payan C, Fermanian J, Pedarriosse AM, Manfredi R.
    Br J Psychiatry; 1992 Apr 20; 160():519-24. PubMed ID: 1571752
    [Abstract] [Full Text] [Related]

  • 38. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B, Benfield P.
    Drugs; 1996 Sep 20; 52(3):450-74. PubMed ID: 8875133
    [Abstract] [Full Text] [Related]

  • 39. Moclobemide: therapeutic use and clinical studies.
    Bonnet U.
    CNS Drug Rev; 2003 Sep 20; 9(1):97-140. PubMed ID: 12595913
    [Abstract] [Full Text] [Related]

  • 40. Successful treatment of tardive akathisia with moclobemide, a reversible and selective monoamine-oxidase-A inhibitor. A case study.
    Ebert D, Demling J.
    Pharmacopsychiatry; 1991 Nov 20; 24(6):229-31. PubMed ID: 1687486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.